India’s COVID-19 caseload climbs to 97.67 lakh; recovery rate at 94.74%, fatalities at 1.45%
Active cases remained below four lakh for the fourth consecutive day. India's COVID-19 tally went past 70 lakh on 11 October, 80 lakh on 29 October and 90 lakh on 20 November
Delhi seeks lockdown in potential COVID hotspots, WHO praises UP's pandemic response; tally at 88.74 lakh
Delhi recorded over one lakh new coronavirus cases and around 1,200 deaths between 1 and 16 November, prompting Arvind Kejriwal to seek power from the Centre to impose lockdown in those markets which may emerge as hotspots
WHO chief Tedros Adhanom Ghebreyesus lauds Narendra Modi’s ‘strong commitment’ to COVID vaccine development
The PM and world health body chief discussed the value of traditional medicinal systems, with the latter appreciating India’s Ayushman Bharat scheme and campaign against tuberculosis
New COVID-19 deaths, cases registered nearly 30% decline in October, says Centre
The country’s coronavirus count rose to 81,84,082 on Sunday with 46,963 new cases being recorded in the last 24 hours, as per the 8 am data update from the Union Health Ministry
ICMR mulls setting up registry of hospitalised COVID-19 patients to collect data on response treatments
Fifteen institutions of national repute would be the registry sites and would mentor around 100 COVID-19 hospitals where the data would be collected
Eid-al-Adha 2020: Mosques, markets wear deserted look as devotees offer prayers at home
Eid-Al-Adha 2020: Temperature screening was being conducted at Delhi's Jama Masjid, while a sanitiser tunnel was set up at a mosque in Bengaluru
Human trials of Indian COVID-19 vaccine candidates mark ‘beginning of pandemic’s end’, writes Vigyan Parisar scientist
Aiming to launch a COVID-19 vaccine by 15 August, ICMR had written to select medical institutions to expedite clinical trials for the candidate COVAXIN
Day after ICMR's clarification on coronavirus vaccine, IASc calls timeline 'unprecedented and unfeasible'
A day after the ICMR announced that it aims to launch a COVID-19 vaccine by 15 August, it issued a clarification saying the process to expedite trials was in accordance with norms